The largest database of trusted experimental protocols

488 protocols using rifampicin

1

Generating Antibiotic-Resistant C. difficile Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Toxigenic strain 630Δerm tcdA:erm(B), containing an ermB gene inserted within tcdA (630ΔtcdA), toxigenic 630Δerm tcdB:erm(B), containing an ermB gene inserted within tcdB (630ΔtcdB) and non-toxigenic strain CD37 (PCR ribotype 009) were donated by Dr. Sarah Kuehne (University of Birmingham, Birmingham, UK) and Dr. Peter Mullany (University College, London, UK), respectively. Strain 630Δerm was typed by REA [11 (link)] as toxigenic REA type R30. Strain CD37 was typed as REA type T18, a new member of the nontoxigenic REA group T. NTCD-M3 was isolated in our lab in 1987 [8 (link)]. Rifampicin–resistant mutants of NTCD- M3 (original Rifampicin MIC 0.25μg/ml) were generated by serial streaking onto taurocholate-fructose agar (TFA) plates [12 (link)] containing increasing amounts of Rifampicin (Sigma-Aldrich, St. Louis, MO) from 0.5μg/ml to 50μg/ml. NTCD-M3 resistant to Rifampicin at 50μg/ml was designated as isolate 6935 (NTCD-M3r). Antibiotic resistance of C. difficile strains used in mating experiments are shown in Table 1.
+ Open protocol
+ Expand
2

Preparation of Selective Bacterial Growth Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luria–Bertani (LB) agar (Invitrogen—Waltham, MA, USA) plates were prepared according to manufacturer’s instructions. A total of 32 g LB agar powder/1 L ddH2O was autoclaved and used in plain petri dishes. The LB agar rifampicin plates were prepared with the addition of 100 μg/mL rifampicin (Sigma–Aldrich, St. Louis, MO, USA, R3501) after autoclaving.
The BHI (Brain Heart Infusion) agar plates were prepared according to manufacturer’s instructions. A total of 37 g BHI (HIMEDIA, Einhausen, Germany) plus 15 g agar/1 L ddH2O was autoclaved and supplemented with 5 mg hemin (Sigma–Aldrich, St. Louis, MO, USA), 0.1 mg vitamin K1 (Sigma–Aldrich, St. Louis, MO, USA), and preferentially 100 μg/mL rifampicin (Sigma–Aldrich, St. Louis, MO, USA) after autoclaving. All plates were kept at 4 °C until usage.
+ Open protocol
+ Expand
3

Rifampicin-resistant APEC O78 Isolation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
APEC O78 (GenBank accession no. CP004009) (Tim Johnson, University of Minnesota, Saint Paul, MN, USA) (57 (link)). Rifampicin resistant APEC O78 (RifR) was isolated on Luria-Bertani (LB) agar (Sigma-Aldrich, Inc. MO, USA)containing 50 μg/mL of Rifampicin (EMD Millipore, USA) (58 (link)). For the preparation of bacterial inoculums, APEC O78 (RifR) was grown overnight in LB media containing 50 μg/mL of Rifampicin at 37°C with shaking at 200 rpm. The bacteria were then diluted 1:100 in fresh LB broth and was incubated with shaking at 200 rpm at 37°C for 3 h. Logarithmic phase grown culture of RifR APEC O78 (OD600 ~ 0.5) was washed twice with PBS and adjusted to the required concentration (OD600 = 0.1).
+ Open protocol
+ Expand
4

Quantifying Mutagenic Effect of OEO

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mutagenic effect of OEO was determined by calculating the rate of mutants resistant to rifampicin due to point mutations in the rpoB gene [10 (link),59 (link)]. Overnight culture of SaWT was diluted 1:10,000 into 50 mL TSBYE and incubated at 37 °C and 130 rpm for 24 h. This culture was then diluted 1:3 in tubes containing 10 mL TSBYE with 750 µL/L of OEO (same concentration used in the evolution assay) and without OEO. This experiment was also carried out with carvacrol (Sigma-Aldrich) at 50 µL/L as control of natural compounds from previous study [10 (link)] and with rifampicin (Sigma-Aldrich) at 0.01 mg/L concentration as a positive control of mutagenesis. Those suspensions were grown at 37 °C and 130 rpm for 24 h (ca. 2 × 109 CFU/mL). Samples of the culture were serially diluted in PBS and pour-plated on TSAYE in the presence and absence of 100 mg/L rifampicin (Sigma-Aldrich). Plates were incubated at 37 °C for 48 h and colonies were counted. Mutation rates were calculated by dividing the number of colonies present in rifampicin plates (mutation events) by the number of colonies present in plates without antibiotic [60 (link)].
+ Open protocol
+ Expand
5

Lactobacillus reuteri Strain Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
L. reuteri and EHEC strains used in this study are listed in S1 Table. The EHEC strain FCH6 (O157:H7, eae+, stx1-, stx2+) had been isolated from a case of HUS in 2004 due to the consumption of raw milk cheese. EHEC strains were routinely cultured in Luria Bertani (LB) broth (Biokar, Beauvais, France). L. reuteri strains were routinely cultured in De Man, Rogosa and Sharpe (MRS) broth (Biokar, Beauvais, France). Spontaneous rifampicin-resistant mutants of L. reuteri and EHEC strains were isolated on MRS agar (pH 6.8) and LB agar plates containing 100 μg/mL of rifampicin (Sigma-Aldrich, St Quentin Fallavier, France), respectively. Each wild-type strain and its corresponding spontaneous RifR mutant showed identical growth patterns. Sensitivity of the rumen microbiota to rifampicin was confirmed by spotting 100 μL of rumen fluid (RF) samples on MRS agar plate containing rifampicin (50 μg/mL) before incubation at 39°C for 24 hours. Survival of L. reuteri in RF was tested by incubating RF samples (from O2-free, CO2-saturated sterile flasks) inoculated with L. reuteri RifR under anaerobiosis (39°C). The next day, the RF samples were 10-fold serially diluted in sterile phosphate buffered saline (PBS) buffer (pH 7.4), plated on MRS agar plates containing rifampicin and incubated overnight under anaerobiosis at 37°C for CFU counting. The experiments were replicated three times.
+ Open protocol
+ Expand
6

Rifampicin Pulmonary Delivery Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rifampicin (Sigma Aldrich, Rockville, MD, USA) was used as a drug of choice, sodium alginate (Sigma Aldrich, Rockville, MD, USA) and aloe vera powder (MINATURE, MARUDHRA IMPEX, Ahmadabad, India) were utilized as matrix former, L-leucine (Sigma Aldrich, Rockville, MD, USA) was added as spray drying excipients. Phosphate buffer saline (Sigma Aldrich, Rockville, MD, USA) was used as a dissolution medium to mimic lung fluid. Methanol (Sigma Aldrich, Rockville, MD, USA) was used as a solubilizing medium for Rifampicin. All other chemicals used were of analytical grade and utilized without any further purification.
+ Open protocol
+ Expand
7

Developing Rifampicin-Resistant Pseudomonas for Grapevine Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The endophytic colonization of grapevine tissues by Pseudomonas was studied using a laboratory-induced rifampicin-resistant (RifMut) strain from BCA17 (P. poae). The RifMut strain was developed following the methods of Adorada et al. [72 (link)] and West et al. [27 (link)]. A single colony of BCA17 was streaked onto NA amended with 1 ppm of rifampicin (Sigma Chemical Co., St. Louis, MO, USA) and resulting colonies subsequently exposed to increasing concentrations of rifampicin (5, 10, 50, and 100 pm). The final resistant strain, now referred to as RifMut, was re-inoculated onto NA with 100 ppm rifampicin on five subsequent occasions to ensure the stability of the resistance.
+ Open protocol
+ Expand
8

Plasmid Conjugation Assay in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conjugation experiments were performed with the plasmid-free recipient strain E. coli HK225 (Strepr, Rifr; Kayser et al., 1982 (link)). Briefly, single colonies of the donor and recipient were inoculated in LB broth (Difco Laboratories) and grown overnight at 37°C. Subsequently, equal volumes of the donor and recipient cultures were mixed and incubated overnight at 37°C without shaking. Serial dilutions were then plated on LB agar (Difco Laboratories) selection plates supplemented with a combination of 600 μg/ml streptomycin (Sigma–Aldrich, Buchs, Switzerland) 100 μg/ml rifampicin (Sigma–Aldrich) and 10 μg/ml cefotaxime (Sigma–Aldrich).
The conjugation frequency per donor was determined by plating serial dilutions of the mating on selective plates on which the donor strain and the transconjugant can grow (LB-agar supplemented with 10 μg/ml cefotaxime) as well as on plates on which only the transconjugants can grow (LB-agar supplemented with 600 μg/ml streptomycin, 100 μg/ml rifampicin, and 10 μg/ml cefotaxime). The transfer frequency was calculated as the quotient of the number of transconjugants over the number of transconjugants plus donors.
+ Open protocol
+ Expand
9

Isolation and Identification of Anaerobic Gut Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Feces and large-intestine scraping were cultivated with selective medium on TSA Tryptic Soy Agar (Tryptic Soy Agar, DIFCO, Taiwan, China, cat no. 211043) supplemented with 5% sheep blood, 6.25 mg/μL rifampicin (rifampicin, Sigma-Aldrich, St. Louis, MO, USA, cat no. R3501), and 800 mg/L spectinomycin (Sigma-Aldrich, cat no. S9007), 25 mg/μL vancomycin (vancomycin, Sigma-Aldrich, cat no. V2002), 25 mg/L of colistin (colistin, Sigma-Aldrich, cat no. C1511) [32 (link)], and incubated for at least three days at 42 °C in jars with an anaerobic atmosphere. Anaerobic conditions were generated using a vacuum pump filled with a mixture of N2 (80%), CO2 (10%), and H2 (10%) gases. To obtain pure colonies, several passages were performed until isolation. The isolates were stored in a freezer at −80 °C.
For differential diagnosis, at the end of the experiment, mucosal scrapings from the small intestine were cultivated on blood agar and MacConkey to evaluate the growth of enterotoxigenic Escherichia coli and scrapings from the large intestine mucosa were cultivated in Rappaport broth and Hectoein agar for Salmonella spp.
+ Open protocol
+ Expand
10

Quantifying CYP3A4 Expression in HLOs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression level of CYP3A4 was analyzed by using the P450-Glo CYP3A4 assay kit (Promega; V9001) and following the manufacturer’s recommended protocol. Rifampicin (Sigma; R3501) was used as an inducer of the CYP3A4 gene at the concentration of 25 μM. Briefly, on day 25, HLOs on the pillar plate were treated with Rifampicin for 3 days with daily medium changes. After treatment, HLOs were incubated with luciferin IPA-substrate at a final concentration of 3 μM diluted in basal HCM medium (without EGF), overnight at 37°C in the CO2 incubator. Following the overnight incubation, 25 μL of the culture medium from each well of the 384DeepWellPlate was transferred to the opaque white 384-well plate at room temperature, and 25 μL of luciferin detection reagent was added in each well to initiate a luminescent reaction. After 20 minutes of incubation at room temperature, luminescence was measured by using the BioTek® Cytation 5 plate reader.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!